Atlas Trials

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG

Clinical trial NCT04790682 · RECRUITING

Trial details

NCT number
NCT04790682
Sponsor
Institut Curie
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Lung Cancer
Start date
2021-05-22
Primary completion
2029-06-03
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.